-
Alcaraz withdraws from Cincinnati Masters with wrist injury
-
Kgatlana strikes as South Africa reach WAFCON quarter-finals
-
SpaceX revenue jumps 92% in first earnings report, but shares slide
-
Pakistan close on series-levelling win against West Indies
-
US eyes Hormuz deal 'today or tomorrow' as ship sinks in Red Sea
-
Paramount CEO says politics fueling Warner Bros. merger battle
-
SpaceX revenue jumps 92% in first earnings report
-
Trump's sale of access to Truth Social raises eyebrows
-
New commissioner Berg wants to take MLS to 'next level'
-
SpaceX rocket stage expected to slam into Moon
-
Colombian ex-guerrillas fear for future under hardline president
-
US hopeful Hormuz strait deal will be done 'today or tomorrow'
-
Tsitsipas comeback continues with Montreal first-round win
-
Michigan primary puts Democratic divide on the ballot
-
Swiatek fends off Bejlek to reach Toronto third round
-
South Africa captain Kolisi to make Test return in Argentina
-
Reusser romps to overall lead at Tour de France Femmes
-
Cuba's famed resilience comes at a growing mental cost
-
McDonald's reports slower US sales in 2nd quarter
-
Swiss Reusser wins Tour de France Femmes time-trial
-
Arsenal step up bid to sign Newcastle's Guimaraes: reports
-
Hundreds flee homes after Guatemala's Fuego volcano erupts
-
Gazans hold mass funeral for those killed during war
-
Thousands pay tribute to Italian football legend Baresi
-
WHO pleads for more support to tackle Ebola outbreak
-
Oil drops, stocks hit records on hopes of Hormuz opening
-
Oil drops, stocks gain on hopes of Hormuz opening
-
Renard returns as Ivory Coast coach
-
Infantino faces nervy times to see if challenger emerges
-
Italian garbagemen help recover lost 1 mln euro lottery ticket
-
Greece gains ground against blaze near Athens
-
EU nations patch things up after Ceuta migration discord
-
Oil turns lower, stocks gain on hopes of Hormuz opening
-
US hopeful Hormuz strait deal will be done 'today or tomorrow' after ship hit
-
World Bank warns developing countries to embrace AI or be left behind
-
Infantino's problems mount as Wenger and key FIFA ally turn on him
-
'No decision' on Mudryk future after Chelsea return: Alonso
-
Oil edges higher, stocks gain as investors eye political risks
-
China draws up safety rules for autonomous vehicles
-
Man Utd sign reported record £20mn sponsorship deal for training kit
-
Wenger says scrapping Infantino's World Cup plan was "absolutely necessary"
-
Stokes reveals England coaching ambition
-
Spain confronts EU migration hawks in tense Ceuta talks
-
Cargo ship hit after Trump insists Iran talks could reopen Hormuz today
-
Firefighters hope to contain blaze on Athens outskirts
-
BP profit soars as Mideast war roils energy prices
-
Heatwave divides rich and poor of upmarket Seoul
-
Most stock markets gain, while oil prices edge up after plunge
-
Drone strike on Moscow region kills 5
-
Most stock markets gain, while oil prices edge up after latest plunge
'Pharma Bro' Shkreli released to halfway house in US
So-called "Pharma bro" Martin Shkreli has been released from a Pennsylvania prison to a halfway house in New York state, the US Bureau of Prisons said Wednesday.
Shkreli, who became a poster child for predatory pharmaceutical pricing before being convicted of securities fraud in 2017, was transferred Wednesday from a low-security prison in Allenwood, Pennsylvania to undisclosed "community confinement" in New York state, said a BOP spokesperson in an email.
He is scheduled to be released from BOP's custody on September 14, the spokesperson said.
Shkreli's attorney, Benjamin Brafman, confirmed the release, saying he was "pleased" to report that his client was let out early "after completing all programs that allowed for his prison sentence to be shortened," according to a statement.
"While in the halfway house I have encouraged Mr. Shkreli to make no further statement, nor will he or I have any additional comments at this time."
Once dubbed "the most hated man in America," Shkreli, 39, became infamous for suddenly raising the price of the HIV drug Daraprim in 2015 by 5,000 percent -- from $13.50 a pill to $750.
Shkreli was originally sentenced in 2018 to seven years in prison in a fraud case not directly related to the Daraprim matter. He has been in custody since September 2017.
L.Dubois--BTB